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Abstract
Artificially roughened gold surfaces with controlled nanostructure produced by pulsed laser deposition have been investigated as
sensors for apomorphine detection aiming at clinical application. The use of such gold surfaces has been optimized using aqueous
solutions of apomorphine in the concentration range between 3.3 × 10−4 M and 3.3 × 10−7 M. The experimental parameters have
been investigated and the dynamic concentration range of the sensor has been assessed by the selection of two apomorphine surface
enhanced Raman scattering (SERS) peaks. The sensor behavior used to detect apomorphine in unfiltered human blood plasma is
presented and discussed.
Introduction
In recent years, the analytical applications of Raman spec-
troscopy and its enhanced variant employing plasmonic media,
the surface enhanced Raman scattering (SERS) effect, have
significantly grown [1-7]. These applications have been fostered
by the availability of noble metal nanostructures, which are
either intentionally fabricated with the aim of optimizing the
signal intensity and reproducibility [2,3] or carefully functional-
ized for the selective and sensitive detection of, for example,
tumor cells [4]. Combining the SERS effect with scanning
probe microscopy techniques (tip-enhanced Raman spec-
troscopy, TERS), molecular information can be obtained with
high spatial resolution to show differences in the local chemical
composition of, for example, a single tobacco virus [8].
The various SERS substrates reported in the literature and the
associated experimental approaches to detect the spectroscopic
signal attest the significant interest for SERS as a powerful,
molecule sensitive, analytical technique. For instance, gold
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colloids synthesized by laser ablation in liquids, suitably func-
tionalized and tagged with Raman reporters, have effectively
revealed specific biomolecules, even in chemically complex
environments such as cells [9-12]. On the other hand, silver and
gold colloids produced by chemical routes can be effectively
used to detect specific analytes of biomedical interest [13-16].
They can also reveal subtle chemical differences in samples
from controls and from patients for specific cancer types [17].
Nanofabricated plasmonic substrates bear interesting perspec-
tives for the detection of low concentration analytes in biomed-
ical scenarios [18]. The interest in the use of plasmonics for
enhancing optical spectroscopy techniques is certainly growing
in the scientific community. This is testified by the recent birth
of a series of international conferences on enhanced spec-
troscopy techniques [19,20].
In this work, we report on the use of gold nanoparticle (NP)
arrays deposited on standard glass substrates to quantitatively
detect apomorphine (APO) aiming at the realization of a
biomedical sensor. APO has been long used in the treatment of
patients with complicated Parkinson’s disease (PD). Indeed one
of the challenging problems in the management of PD is the
development of severe, long-term motor complications that oral
medication cannot adequately control at tolerable doses.
Presently, APO delivered via continuous subcutaneous infusion
is one of the viable alternatives to oral medication in such
patients. Adjusting the APO concentration as it fluctuates with
time is critical and is monitored via standardized clinical obser-
vations and tests of motor condition [21]. Standard chemical
analysis (HPLC) on blood samples from the patient is an alter-
native to obtain the APO concentration. Au NPs were synthe-
sized by pulsed laser ablation of a metal target in inert gas at
high pressure. With respect to free expansion in vacuum, the
ambient gas modifies the expansion of the plasma plume,
consisting of species ablated from the target surface. Depending
on the nature of the gas and the pressure, significant volume
contraction of the propagating plume can be achieved,
providing ideal conditions to synthesize NPs. By changing the
process parameters (in particular, the number of laser pulses,
laser pulse energy and spot size on the target, gas characteris-
tics and pressure), NPs with different sizes are produced and NP
arrays with different degrees of surface coverage on the sub-
strate (corresponding to strongly differentiated morphologies)
are obtained in a finely controlled way [22-25]. Such nanostruc-
tured, artificially roughened surfaces are characterized by plas-
monic properties, such as the frequency and width of the
plasmon resonance, that can be tailored exploring wide inter-
vals [26]. This makes them suitable for use as substrates for
SERS, and in particular, to detect exiguous amounts of analyte
with low-intensity Raman signatures or that are hindered by
competitive fluorescence. A thorough exploration of the mor-
phology versus performance relation for Au substrates with
strongly different morphologies tested against various analytes
indicates that films consisting of NPs mutually assembled to
form islands separated by channels give the best SERS signal
enhancements. The analytes tested range from a straightfor-
ward SERS label (RH6G) to organic dyes of interest in art
conservation (Alizarin, Purpurin) to small proteins (lysozime).
These results also indicate that there is a trade-off between the
size of the analyte and the average size of the inter-island chan-
nels where the analyte is pinned to the substrate [27]. SERS
spectra obtained with such substrates are remarkably repro-
ducible and spatially uniform [28,29] thus they appear suitable
to be used to rapidly measure the concentration of drugs in
blood plasma. We note that, although in principle such
substrates can be functionalized, for simplicity, we avoid this
strategy since APO can be chemisorbed on the Au surface,
giving sizeable SERS features.
Experimental
Production of gold substrates and SEM
characterization
The substrates were prepared in a vacuum chamber at a base
pressure lower than 10−4 Pa. A KrF excimer laser (λ = 248 nm,
pulse width 25 ns, repetition rate 10 Hz) was focused onto a
pure gold target (99.99%) mounted on a rotating holder. The
substrates were deposited on pieces of Corning Glass 5049, or
Si(100), placed at a distance of 35 mm from the target and held
at room temperature. The target holder was rotated to avoid
target surface cratering under repetitive ablation. The ablation
was performed in an Ar atmosphere at a pressure of 100 Pa. The
number of laser pulses was fixed at 10,000. The laser fluence
was kept constant at 2.0 J/cm2. The sample morphology was
observed by scanning electron microscopy (SEM) using a Zeiss
Supra 40 field ion microscope.
Preparation of APO solutions
For the preparation of APO solutions at different concentra-
tions, the commercially available Apofin solution for subcuta-
neous injection (Chiesi Farmaceutici, Parma, Italy) was used.
The commercial drug (3 mL) contains 30 mg of apomorphine
hydrochloride (Mw = 303.78332 g/mol) as the active ingredient,
corresponding to a molar concentration of 3.3 × 10−2 M of
R-apomorphine, plus sodium metabisulfite and hydrochloric
acid as excipients.
The APO solutions were obtained by suitable dilution of the
commercial drug with sterile water for injection (B. Braun) to
reach the final concentrations of 100, 10, 1 and 0.1 µg/mL (i.e.,
from 3.3 × 10−4 M to 3.3 × 10−7 M). The pH values of all solu-
tions were in the range between 5.5 and 6.5, as determined by
indicator paper.
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SERS of APO in aqueous solution and data
processing
The gold SERS-active substrates were dipped in freshly
prepared APO solutions (1 mL of each solution in a glass vial)
for a fixed time and air-dried before acquiring SERS spectra.
Three different dipping times were considered, namely 2, 5 and
10 min, in order to evaluate the best contact time for the solu-
tion and the substrate.
The gold substrates subjected to the dipping and drying proce-
dure were observed with an Olympus BX41 microscope using a
50× Olympus objective (NA = 0.75) coupled to the spectrom-
eter, and different points for each sample were chosen for SERS
measurements. All SERS spectra were collected by a Jobin-
Yvon LabRAM HR800 Raman spectrometer with a solid-state
laser (Laser XTRA, Toptica Photonics) operating at 785 nm,
equipped with a 600 grooves mm−1 grating and a Peltier-cooled
CCD detector. Notch filters for 785 nm were used to suppress
the Rayleigh scattering. The laser was focused on the sample
through the same 50× Olympus objective (NA = 0.75), with a
nominal laser power irradiation at the samples of 1 mW, over a
spot size of about 1 µm, and an exposure time of 2 to 30 s
(average of 2 accumulations). The spectra were recorded in the
region between 900 and 1800 cm−1, where the most intense
Raman features of apomorphine lie [30].
Two SERS peaks, namely at 1353 cm−1 and 1515 cm−1, were
selected as intense, stable and reproducible markers for APO
detection in aqueous solutions. The corrected areas under each
peak were evaluated by manual selection of the baseline using
Omnic 8 software (Thermo Fisher Scientific, Inc.). From
repeated measurements at different spots, a mean value and
standard deviation from the mean were calculated and studied
as a function of drug concentration in order to assess the
dynamic range of concentration of the sensor. Different fits
were applied to the data (Sigma Plot, Systat Software, Inc.,
USA) to describe the concentration dependence in the range
between 1 and 100 µg/mL.
The SERS peak areas were normalized with respect to the peak
area for the highest concentration studied (i.e., 100 µg/mL), and
plotted as a function of the logarithm of the APO concentration,
in order to compare experimental data at different dipping
times. A linear regression was applied to the data sets.
SERS of APO in blood plasma
In order to prove the feasibility of the method for the detection
of APO in real samples, some initial trials were carried out on
unfiltered blood plasma from a healthy volunteer (Fondazione
I.R.C.C.S. Istituto Neurologico Carlo Besta, Milano, Italy). The
samples of plasma were supplemented with apofin to produce
Figure 1: (A, B) SEM micrographs of the surface morphology of a gold
substrate deposited at 100 Pa in Ar with 104 laser pulses. Insets in (A)
represent typical average sizes of the inter-island channels
(Pa1 = 12.54 nm and Pa2 = 14.20 nm).
the desired concentrations of 200, 20, and 2 µg/mL of APO in
plasma.
Starting from the lowest APO concentration (2 µg/mL), one
SERS sensor was dipped for 5 min in 1 mL of plasma and dried
in air before acquisition of the spectra. The experimental proce-
dure was repeated, dipping the same sensor in plasma
containing APO at 20 µg/mL for 2 min. The sensor was finally
dipped for 2 min in the most concentrated sample (200 µg/mL),
air-dried and measured. All spectra were collected in the
900–1800 cm−1 spectral range with exposure times of 5, 10, 30
and 60 s (average of 2 accumulations).
Results and Discussion
Morphology of nanostructured gold
substrates
Figure 1 shows representative pictures of the surface morpholo-
gy of the nanostructured gold substrates used as sensors for
APO detection. The films consist of nearly spherical, mutually
aggregated, Au NPs that give rise to islands with irregular
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Figure 2: (A) SERS spectra of 100 µg/mL APO (dipping time: 5 min) collected with different exposure times on different areas of the gold substrate,
and baseline-corrected peak areas versus acquisition time for two selected APO-intense Raman features at (B) 1515 cm−1 and (C) 1353 cm−1.
shape, often interconnected with each other at specific sites.
The channels with irregular shape and length separate adjacent
islands. The insets of Figure 1A show typical average sizes of
such inter-island channels. SERS hinges on the strong inter-
action between noble metal NPs and visible light through the
resonant collective excitation of NP conduction electrons. The
resulting surface plasmon resonance peak [28] displays a
maximum at about 780 nm. This peak position is optimized by
controlling the film nanostructure and allows the fluorescence
to be kept as low as possible. No appreciable changes in the
peak position and shape were observed after dipping the
substrates in the solutions. The locally enhanced electric field
decays abruptly within a tiny region of nanometer thickness
around a given particle, with a marked dependence of the
enhancement factor on the details of the local surface nano-
roughness. The size of the inter-island channels makes them
likely to have a twofold role. They are suitable to provide pref-
erential, direct adsorption sites for the comparatively small
molecular species to be studied. Here they can effectively
interact with Au atoms and concurrently constitute hot spots
where most of the relevant SERS enhancement occurs. This
condition allows for the opportunity to optimize the nanostruc-
ture to be selective toward small species, such as drug mole-
cules, with respect to a more bulky chemical species, for
example, proteins in biological fluids. It is noteworthy that
the above-discussed features of the artificially roughened
surface in Figure 1A are homogeneous over areas of the order
of 5 × 103 nm2, as shown in Figure 1B. Such Au substrates are
thus expected to display spatially uniform optical behavior. The
typical enhancement factor determined for these substrates is
107 [24].
SERS spectra of APO aqueous solution
The SERS spectra of 100 µg/mL APO collected with different
exposure times, ranging from 2 to 30 s, on different areas of the
gold substrate are shown in Figure 2A. The substrate was
dipped for 5 min in 1 mL of APO solution and air-dried before
acquiring the SERS spectra.
By comparing the spectra, no meaningful changes in the spec-
tral profile are observed during the measurements for the
different exposure times. The selected experimental conditions
(nominal laser power of 1 mW at the sample, spot size of about
1 µm, accumulation times of no longer than 30 s) are suitable to
detect the analyte without producing any chemical degradation
of the drug molecule during the measurements by interacting
with the gold surface. The rapid acquisition time, together with
a relatively low laser power, represent promising conditions for
a rapid method for the measurement of the concentration of
drugs in biological fluids. A spot size of about 1 µm ensures the
collection of an average SERS signal from the selected area,
given that inter-island channels of the nanostructured Au sub-
strate are, on average, in the 10 nm range (see Figure 1).
The main SERS active modes of APO are found at 1009, 1035,
1091, 1179, 1199, 1223, 1353, 1392, 1515, 1579 and
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1618 cm−1, in agreement with previous experimental and theo-
retical investigations [30].
The closeness of the molecule to the nanostructured metal
surface is an inherent condition for SERS enhancement. There-
fore, the assignment of experimental peaks to specific vibra-
tional modes of the analyte is important to understand the kind
of interaction between the molecule and the substrate. The
assignment of the peaks also has a more practical meaning: it
facilitates the selection and definition of appropriate spectral
features that can be employed to recognize, and in some
cases, to quantify, the analyte in progressively more complex
matrices. The effort to resolve the analyte signals with respect
to the overall spectrum, including contributions from
interfering species, is a critical step once dealing with real
samples.
Among the strongest peaks of the APO SERS spectrum, two
signals were selected, specifically the peak centered at
1353 cm−1 (aromatic C–H in-plane bending, N–H bending,
collective C–C stretching, CH2 wagging), and the one centered
at 1515 cm−1 (C–C stretching of ring A, C–O stretching), in
order to elucidate any dependence of the SERS signal on the
experimental and instrumental parameters. Both wavenumbers
fall in spectral regions where the SERS spectrum of blood
plasma does not display any characteristic band. Using the near-
infrared excitation at 785 nm, the spectra are dominated by
protein bands with broad amide bands at 1650 cm−1 (amide I)
and 1250 cm−1 (amide III), and sharp bands due to aromatic
amino acids at 1004 cm−1 (Phe), 1127 cm−1 (Tyr) and CH2/CH3
deformations at 1450 cm−1 [31].
A manual baseline correction was applied to the raw data, and
average values were plotted versus the acquisition time, as
shown in Figure 2B. A linear regression was applied to the two
data sets. The linearity of the SERS response confirms the
observation that any of the selected acquisition times are suit-
able to detect intense APO signals, with no analyte degradation
occurring during the measurement. This behavior also confirms
the previously assessed [28,29] spatial reproducibility of the
signal.
Assessment of the concentration dynamic
range of the sensor
To be considered a useful SERS-based method for drug detec-
tion, the procedure, based on the use of gold substrates pulsed
laser deposition, should be rapid and quantitative. An acquisi-
tion time of 5 s, which corresponds to a fast measurement with
an adequate signal-to-noise ratio (see Figure 2A), was chosen
for the SERS measurements of APO aqueous solutions at
different concentrations. To explore the dynamic range of the
sensor, the Au SERS-active substrates were tested with respect
to APO concentrations of 100, 10, 1 and 0.1 μg/mL.
Figure 3 shows a set of representative SERS spectra recorded
with the above conditions. At the lowest concentration
(0.1 µg/mL), only a weak signature at 1515 cm−1 is found.
Different acquisition times, up to 30 s, did not result in an
evident improvement in signal quality.
Figure 3: SERS of APO solutions at four different concentrations (100,
10, 1, 0.1 µg/mL; dipping time 5 min; 5 s acquisition time). The peaks
at 1515 cm−1 and 1353 cm−1 were selected to evaluate the SERS
signal dependence on the APO concentration.
Starting from the concentration of 1 µg/mL, the intensity of
APO peaks increases with APO concentration, while the pos-
ition of all characteristic peaks remains unchanged. Dilution
with water produces a change in the measured pH values of
APO solutions from 5.5 for the most concentrated solution to
6.5 for the diluted solutions; such variations have no effect on
the spectral features.
If the peak area is plotted against the concentration of the APO
solutions, a characteristic trend is found, where a steep growth
for low concentrations (between 1 and 10 µg/mL, notice that the
lower limit falls within the range of clinical interest) and the
onset of saturation near the highest tested concentration
(100 µg/mL, see Figure 4) is observed.
These data points summarize quite well the whole dynamic
range of concentrations of the sensor for APO detection in
aqueous solution. The reduced number of selected concentra-
tions allows for the exploration of the role of different experi-
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Figure 4: Peak areas (baseline-corrected) plotted against the concentration of APO solutions that summarize the dynamic concentration range of the
substrate as a sensor for APO detection in aqueous solution. In particular (A) and (B) show a fit to a hyperbolic function of the data for 1515 cm−1 and
1353 cm−1 APO peaks; (C) and (D) show a fit to a logarithmic function of the data for the same peaks. The fitting parameters are (A) a = 2003,
b = 0.15; (B) a = 773, b = 0.11; (C) y0 = 3476, a = 1948 and (D) y0 = 1125, a = 1143.
mental conditions on the sensor behavior in detail. For each
point reported in Figure 4, a number of independent measure-
ments (between 3 and 5) on a given sensor allowed the stan-
dard deviation to be estimated. This approach, together with the
selected APO concentrations, is the best compromise to probe
the dynamic range of the sensor and to test the repeatability of
each measurement, while keeping a manageable number of
sensors.
From the literature, different models were applied to fit the
experimental data taking into account the nonlinearity of the
curve trend when dealing with the quantitative application of
SERS spectroscopy. The Langmuir isotherm was applied to
qualitatively describe the concentration dependence and to find
a nonlinear calibration curve for ten common narcotic drug
analytes [32], while linear regression curves were generated
from experimental data for glucose detection [33].
The coefficients of determination, R2, shown in Figure 4 indi-
cate that a logarithmic model fits the experimental data slightly
better than a hyperbolic model. The latter assumes an asymp-
totic limit (saturation), while the former allows the generation
of linear regression curves when SERS peak areas for APO are
plotted as a function of the logarithm of its concentration.
To evaluate the contribution of the dipping time to the defini-
tion of the dynamic range of the sensor, a shorter dipping time
of 2 min (preferable for practical applications) was studied.
The SERS peak areas were normalized with respect to the peak
area for the highest studied concentration (i.e., 100 µg/mL), and
plotted on a semi-logarithmic scale (Figure 5). This way it is
possible to contrast different curves obtained using different
dipping times and to study the impact of this experimental para-
meter on the dynamic range.
A linear regression was applied to the data sets according to
(1)
where I(C) is the Raman intensity of a selected APO peak, C is
APO molar concentration and Cmax = 3.3 × 10−4 M in our
experiments; α and β are the fitting coefficients.
When the dipping time is 2 min, the slopes are α1515 = 0.5 ± 0.2
for the 1515 cm−1 peak, and α1353 = 0.486 ± 0.002 for the
1353 cm−1 peak; when the dipping time is 5 min, these become
α1515 = 0.34 ± 0.07 and α1353 = 0.40 ± 0.04, respectively.
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Figure 5: Effect of the dipping time on the dynamic range of the APO concentration of the gold sensor. Linearized data for different dipping times and
APO peaks: (A) 2 min, 1515 cm−1; (B) 2 min, 1353 cm−1; (C) 5 min, 1515 cm−1; (D) 5 min, 1353 cm−1.
Figure 6: APO crystal growth on the gold sensor (dipping time 10 min). The scattered data result when plotting peak areas against APO concentra-
tion for (A) 1515 cm−1 peak and (B) 1353 cm−1 peak (see text). (C) Optical microscope image of a representative area of the sensor highlighting APO
crystals (dark spots).
Hence, the dipping time has a moderate role in the sensitivity of
the sensor, and it could be conveniently optimized in order to
reach the lowest detectable concentration for any chosen nano-
structured, gold substrate. On the other hand, for a given
dipping time, the α-parameter is constant with respect to the
Raman mode. This is expected because the relative Raman
intensity of two peaks reflects a molecular property that does
not depend on concentration (i.e., it is a ratio of Raman cross-
sections).
Based on these findings, an additional increase of the dipping
time, while avoiding sensor saturation, could be expected to
cause at least a slight sensitivity increase towards lower analyte
concentrations. A third set of experiments at different APO
concentrations was therefore carried out with a dipping time of
10 min. We observed the growth of APO crystals of a few
micrometers on the surface of the sensor, irrespective of the
concentration. More scattered data correspond to this observa-
tion (Figure 6). This limiting case should be avoided. On the
contrary, optical microscope observation of the sensor surface
did not reveal any distinct feature when the dipping time was 2
or 5 min. It is likely that the observed change in the sensor
sensitivity on the dipping time is associated with changes in the
degree of surface coverage.
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Figure 7: SERS spectra of unfiltered blood plasma with (A) APO 200 µg/mL, and (B) APO 20 µg/mL. SERS spectra of APO aqueous solutions (gray)
are shown for comparison.
SERS measurements of APO in blood
plasma
To prove the applicability of the proposed method to the detec-
tion and quantification of APO in blood samples, a few experi-
ments were performed on unfiltered blood plasma with different
APO concentrations. These challenging conditions were chosen
to minimize sample preparation, while still demonstrating the
feasibility of the proposed technique.
The SERS spectra are shown in Figure 7, where protein bands
are noticeable at 1652 cm−1 (amide I), 1254 cm−1 (amide III),
1034 cm−1 and 1004 cm−1 (Phe).
In Figure 7A the SERS spectrum of 200 µg/mL APO in blood
plasma shows intense peaks that can be ascribed to APO.
Among these, the two peaks at 1515 and 1353 cm−1, selected
for APO detection in aqueous solution, are clearly visible and
found at 1520 and 1348 cm−1, respectively. Such differences in
peak position can be possibly ascribed to the complexity of
interactions that the drug molecule experiences in the bio-
logical matrix as compared to the aqueous solution. To reach a
comparable SERS intensity with respect to 100 µg/mL APO in
water, an acquisition time of 10 s was applied, while 60 s was
the acquisition time required for a reasonable signal-to-noise
ratio of the SERS spectrum of 20 µg/mL APO in blood plasma,
as shown in Figure 7B.
The kinetics of APO adsorption onto the gold nanostructured
surface are expected to be strongly affected by matrix effects. In
particular, the presence of proteins, such as human serum
albumin, an abundant plasma protein that binds a wide range of
drugs including APO [28], has to be taken into account during
the optimization of the experimental conditions. Hence, dipping
times could be reconsidered to deal with the equilibrium
between APO and proteins in solution.
Furthermore, once dealing with APO detection in clinical
samples, it is possible to introduce minimized sample
preparation (e.g., deproteinization) to enhance the APO signal
intensity.
Conclusion
Gold NP arrays pulsed laser deposited on glass proved to be
suitable sensors for the quantitative detection of APO in water
by means of SERS. The dynamic range of concentrations of the
sensor was assessed by the selection of two SERS peaks.
Minimal sample preparation and the capability to operate in an
aqueous environment make the detection of APO by means of
this technique rapid, with good signal-to-noise ratio, and char-
acterized by adequate spatial reproducibility. The method is
promising for transfer to APO detection in biological fluids.
Experiments performed on unfiltered blood plasma with
different APO concentrations proved the applicability of the
proposed method to APO detection for samples of clinical
origin.
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